In recent times, the TGA has introduced a range of new prescription medicine application pathways that utilise overseas evaluations and accelerate market access. The team at Brandwood CKC have extensive experience with these new pathways and this webinar will outline the latest developments and provide insights as to the pros and cons of each pathway. A must for companies looking to accelerate Australian regulatory approvals and maximise efficiencies in the global roll out of new products.

Presenter: Robert Stringer, Director and Principal Consultant

Podden och tillhörande omslagsbild på den här sidan tillhör Brandwood CKC. Innehållet i podden är skapat av Brandwood CKC och inte av, eller tillsammans med, Poddtoppen.